|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gallmeier E and Gress TM: Pancreatic
ductal adenocarcinoma. Internist (Berl). 59:805–822. 2018.(In
German). View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferrone CR, Pieretti-Vanmarcke R, Bloom
JP, Zheng H, Szymonifka J, Wargo JA, Thayer SP, Lauwers GY,
Deshpande V, Mino-Kenudson M, et al: Pancreatic ductal
adenocarcinoma: Long-term survival does not equal cure. Surgery.
152 (3 Suppl 1):S43–S49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Adamska A, Domenichini A and Falasca M:
Pancreatic ductal adenocarcinoma: Current and evolving therapies.
Int J Mol Sci. 18(pii): E13382017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ishiwata T: Pancreatic ductal
adenocarcinoma: Basic and clinical challenges for better prognosis.
J Carcinog Mutagene. S9:0052013.
|
|
7
|
Principe DR, Doll JA, Bauer J, Jung B,
Munshi HG, Bartholin L, Pasche B, Lee C and Grippo PJ: TGF-β:
Duality of function between tumor prevention and carcinogenesis. J
Natl Cancer Inst. 6:djt3692014. View Article : Google Scholar
|
|
8
|
Hesler RA, Huang JJ, Starr MD, Treboschi
VM, Bernanke AG, Nixon AB, McCall SJ, White RR and Blobe GC:
TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in
pancreatic ductal adenocarcinoma through downregulation of the
nucleoside transporters hENT1 and hCNT3. Carcinogenesis.
37:1041–1051. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thakur AK, Nigri J, Lac S, Leca J, Bressy
C, Berthezene P, Bartholin L, Chan P, Calvo E, Iovanna JL, et al:
TAp73 loss favors Smad-independent TGF-β signaling that drives EMT
in pancreatic ductal adenocarcinoma. Cell Death Differ.
23:1358–1370. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu Z, Xu Y, Zhao J, Liu Q, Feng W, Fan J
and Wang P: miR-367 promotes epithelial-to-mesenchymal transition
and invasion of pancreatic ductal adenocarcinoma cells by targeting
the Smad7-TGF-β signalling pathway. Br J Cancer. 112:1367–1375.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo L, Tang H, Ling L, Li N, Jia X, Zhang
Z, Wang X, Shi L, Yin J, Qiu N, et al: LINC01638 lncRNA activates
MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation
in triple-negative breast cancer. Oncogene. 37:6166–6179. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou Y, Gong B, Jiang ZL, Zhong S, Liu XC,
Dong K, Wu HS, Yang HJ and Zhu SK: Microarray expression profile
analysis of long non-coding RNAs in pancreatic ductal
adenocarcinoma. Int J Oncol. 48:670–680. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fu XL, Liu DJ, Yan TT, Yang JY, Yang MW,
Li J, Huo YM, Liu W, Zhang JF, Hong J, et al: Analysis of long
non-coding RNA expression profiles in pancreatic ductal
adenocarcinoma. Sci Rep. 6:335352016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu Z, Zhou J, Zhang Z and Li D: Decreased
expression of lncRNA TMED11P is correlated with progression and
prognosis in pancreatic ductal adenocarcinoma. Int J Clin Exp
Pathol. 9:10550–10556. 2016.
|
|
16
|
Ye Y, Chen J, Zhou Y, Fu Z, Zhou Q, Wang
Y, Gao W, Zheng S, Zhao X, Chen T and Chen R: High expression of
AFAP1-AS1 is associated with poor survival and short-term
recurrence in pancreatic ductal adenocarcinoma. J Transl Med.
13:1372015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Poruk KE, Blackford AL, Weiss MJ, Cameron
JL, He J, Goggins M, Rasheed ZA, Wolfgang CL and Wood LD:
Circulating tumor cells expressing markers of tumor-initiating
cells predict poor survival and cancer recurrence in patients with
pancreatic ductal adenocarcinoma. Clin Cancer Res. 23:2681–2690.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu JH, Chen G, Dang YW, Li CJ and Luo DZ:
Expression and prognostic significance of lncRNA MALAT1 in
pancreatic cancer tissues. Asian Pac J Cancer Prev. 15:2971–2977.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Blobe GC, Schiemann WP and Lodish HF: Role
of transforming growth factor β in human disease. N Engl J Med.
342:1350–1358. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Z, Dong M, Fan D, Hou P, Li H, Liu L,
Lin C, Liu J, Su L, Wu L, et al: lncRNA ANCR down-regulation
promotes TGF-β-induced EMT and metastasis in breast cancer.
Oncotarget. 8:67329–67343. 2017.PubMed/NCBI
|
